234 related articles for article (PubMed ID: 32302553)
21. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
Inui K
Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
[TBL] [Abstract][Full Text] [Related]
22. AAV9-coGLB1 Improves Lysosomal Storage and Rescues Central Nervous System Inflammation in a Mutant Mouse Model of GM1 Gangliosidosis.
Liu S; Ma W; Feng Y; Zhang Y; Jia X; Tang C; Tang F; Wu X; Huang Y
Curr Gene Ther; 2022; 22(4):352-365. PubMed ID: 35249485
[TBL] [Abstract][Full Text] [Related]
23. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
[TBL] [Abstract][Full Text] [Related]
24. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
[TBL] [Abstract][Full Text] [Related]
25. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
Kobayashi T; Shinnoh N; Kuroiwa Y
Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
[TBL] [Abstract][Full Text] [Related]
26. Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.
Weismann CM; Ferreira J; Keeler AM; Su Q; Qui L; Shaffer SA; Xu Z; Gao G; Sena-Esteves M
Hum Mol Genet; 2015 Aug; 24(15):4353-64. PubMed ID: 25964428
[TBL] [Abstract][Full Text] [Related]
27. A case of type 2 Gm1-gangliosidosis with long survival.
Kikuchi K; Minami R; Kudoh T; Nakao T; Tsugawa S
Brain Dev; 1982; 4(2):153-6. PubMed ID: 6807121
[TBL] [Abstract][Full Text] [Related]
28. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis.
Sano R; Annunziata I; Patterson A; Moshiach S; Gomero E; Opferman J; Forte M; d'Azzo A
Mol Cell; 2009 Nov; 36(3):500-11. PubMed ID: 19917257
[TBL] [Abstract][Full Text] [Related]
29. Presynaptic Dysfunction in Neurons Derived from Tay-Sachs iPSCs.
Matsushita K; Numakawa T; Odaka H; Kajihara R; Soga M; Ozasa S; Nakamura K; Mizuta H; Era T
Neuroscience; 2019 Aug; 414():128-140. PubMed ID: 31283907
[TBL] [Abstract][Full Text] [Related]
30. [The role of ophthalmological examination in the diagnosis of gangliosidosis GM1].
Krzywińska-Zdeb E; Gizewska M; Modrzejewska M; Romanowska H; Stecewicz I; Pawłowska A; Tuziak M; Walczak M
Klin Oczna; 2011; 113(7-9):266-9. PubMed ID: 22256571
[TBL] [Abstract][Full Text] [Related]
31. Morphological analysis of corneal opacity in Shiba dog with GM1 gangliosidosis.
Nagayasu A; Nakamura T; Yamato O; Tsuzuki K; Hosaka Y; Ueda H; Tangkawattana P; Takehana K
J Vet Med Sci; 2008 Sep; 70(9):881-6. PubMed ID: 18840960
[TBL] [Abstract][Full Text] [Related]
32. Human
Latour YL; Yoon R; Thomas SE; Grant C; Li C; Sena-Esteves M; Allende ML; Proia RL; Tifft CJ
Mol Genet Metab Rep; 2019 Dec; 21():100513. PubMed ID: 31534909
[TBL] [Abstract][Full Text] [Related]
33. Enhanced Autophagy Contributes to Protective Effects of GM1 Ganglioside Against Aβ1-42-Induced Neurotoxicity and Cognitive Deficits.
Dai R; Zhang S; Duan W; Wei R; Chen H; Cai W; Yang L; Wang Q
Neurochem Res; 2017 Aug; 42(8):2417-2426. PubMed ID: 28497346
[TBL] [Abstract][Full Text] [Related]
34. Pathological findings of central nervous system, two GM1 gangliosidosis autopsy cases.
Kara DÖ; Şahpaz A
Turk J Pediatr; 2019; 61(6):953-957. PubMed ID: 32134593
[TBL] [Abstract][Full Text] [Related]
35. Fetal GM1-gangliosidosis: morphological and biochemical studies.
Ida H; Eto Y; Maekawa K
Brain Dev; 1989; 11(6):394-8. PubMed ID: 2618963
[TBL] [Abstract][Full Text] [Related]
36. GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types.
Suzuki Y; Nakamura N; Fukuoka K
Hum Genet; 1978 Aug; 43(2):127-31. PubMed ID: 99363
[TBL] [Abstract][Full Text] [Related]
37. [The use of loading tests with labeled GM1-ganglioside for differential diagnosis of GM1-gangliosidosis].
Akhunov VS; Krasnopol'skaia KD; Mirenburg TV
Vopr Med Khim; 1989; 35(5):119-22. PubMed ID: 2515652
[TBL] [Abstract][Full Text] [Related]
38. GM1-gangliosidosis in American black bears: clinical, pathological, biochemical and molecular genetic characterization.
Muthupalani S; Torres PA; Wang BC; Zeng BJ; Eaton S; Erdelyi I; Ducore R; Maganti R; Keating J; Perry BJ; Tseng FS; Waliszewski N; Pokras M; Causey R; Seger R; March P; Tidwell A; Pfannl R; Seyfried T; Kolodny EH; Alroy J
Mol Genet Metab; 2014 Apr; 111(4):513-21. PubMed ID: 24581871
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
40. GM1 gangliosidosis: patients with different phenotypic features and novel mutations.
Emecen Sanli M; Dogan M
J Pediatr Endocrinol Metab; 2023 Jun; 36(6):602-607. PubMed ID: 37042746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
